NCT07820267

Brief Summary

This prospective observational cohort study aims to evaluate the prognostic value of serial bedside ultrasound assessment of diaphragmatic function in adult patients with septic shock. Diaphragmatic excursion, thickness, and thickening fraction will be assessed using point of care ultrasound at baseline and serially during the first 72 hours of intensive care admission. Dynamic changes in these parameters will be analyzed in relation to the development of respiratory failure, need for invasive mechanical ventilation, duration of mechanical ventilation, weaning and extubation outcomes, length of ICU stay, and mortality. The study will determine whether dynamic diaphragmatic ultrasound assessment can provide an early, non-invasive predictor of respiratory failure and adverse clinical outcomes in patients with septic shock.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

September 15, 2026

Status Verified

September 1, 2026

Enrollment Period

1.5 years

First QC Date

September 4, 2026

Last Update Submit

September 11, 2026

Conditions

Keywords

POCUSseptic shockrespiratory failurediaphragm

Outcome Measures

Primary Outcomes (4)

  • Number of participants Developing Respiratory Failure Requiring Invasive Mechanical Ventilation.

    Number of participants who develop respiratory failure requiring initiation of invasive mechanical ventilation, assessed by clinical criteria and the requirement for endotracheal intubation and invasive mechanical ventilation.

    From Baseline through Day 7

  • Diaphragmatic Excursion Measured by Point of Care ultrasound

    Diaphragmatic Excursion measured using M mode point of care ultrasound during spontaneous breathing or ventilator supported breathing, as applicable and measured in millimeter. Three measurements will be obtained and averaged.

    Baseline, 24 hours, 48 hours, and 72 hours

  • Diaphragmatic Thickness Measured by Point of Care Ultrasound

    Diaphragmatic thickness measured at the zone of apposition using B mode point of care ultrasound at end expiration and measured in millimeter. Three measurements will be obtained and averaged.

    Baseline, 24 hours, 48 hours, and 72 hours

  • Diaphragmatic Thickening Fraction Measured by Point of Care Ultrasound

    Diaphragmatic thickening fraction measured using point of care ultrasound and calculated as \[(inspiratory thickness-expiratory thickness) / expiratory thickness\] \* 100 and measured in percentage. Three measurements will be obtained and averaged.

    Baseline, 24 hours, 48 hours, and 72 hours

Secondary Outcomes (6)

  • Time to Initiation of Invasive Mechanical Ventilation

    From baseline through Day 7

  • Duration of invasive mechanical ventilation

    From initiation of invasive mechanical ventilation until successful discontinuation of invasive mechanical ventilation, assessed through ICU discharge or up to 28 days, whichever comes first.

  • Number of Participants with Weaning failure

    From the first spontaneous breathing trial until successful liberation from invasive mechanical ventilation or ICU discharge, assessed up to 28 days.

  • Number of Participants With Extubation failure

    within 72 hours after extubation.

  • Duration of Intensive Care Unit stay

    From baseline (ICU admission) until ICU discharge or death, assessed up to 28 days.

  • +1 more secondary outcomes

Study Arms (2)

Patients with septic shock who are not receiving invasive mechanical ventilation at enrollment.

Patients with septic shock who are not receiving invasive mechanical ventilation at enrollment. primary respiratory outcome: Development of respiratory failure requiring invasive mechanical ventilation within 7 days after enrollment.

Patients with septic shock who are already receiving invasive mechanical ventilation at enrollment.

Patients with septic shock who are already receiving invasive mechanical ventilation at enrollment. outcomes: Duration of mechanical ventilation, weaning failure, extubation failure or reintubation, ICU and hospital mortality and ICU length of stay.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adult patients 18 years old or more admitted to ICU with septic shock diagnosed according to the sepsis-3 criteria. Eligible patients will be prospectively enrolled after meeting the predefined inclusion and exclusion criteria and will undergo serial bedside point of care ultrasound assessment of diaphragmatic function during the first 72 hours of ICU admission.

You may qualify if:

  • Age ≥ 18 years old.
  • Patients with septic shock.
  • Patients with ICU admission during study period.
  • Expected ICU stay for at least 72 hours.
  • Informed consent from the patient or legal guardian when required.

You may not qualify if:

  • Age less than 18 years old.
  • Pre-existing neuromuscular disorders affecting respiratory muscles.
  • Known diaphragmatic paralysis or diaphragmatic palsy.
  • Significant phrenic nerve injury.
  • Cervical spinal cord injury.
  • Advanced chronic neuromuscular disease.
  • Previous major thoracic or diaphragmatic surgery.
  • Severe chest wall deformity.
  • Conditions preventing adequate diaphragmatic ultrasound assessment.
  • Pregnancy, if required by local ethical policy.
  • Patients with limitations of care that preclude full respiratory support.
  • Refusal of consent where consent is required.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine, Assiut university

Asyut, 71515, Egypt

Location

Related Publications (15)

  • Dres M, Demoule A. Monitoring diaphragm function in the ICU. Curr Opin Crit Care. 2020 Feb;26(1):18-25. doi: 10.1097/MCC.0000000000000682.

    PMID: 31876624BACKGROUND
  • Llamas-Alvarez AM, Tenza-Lozano EM, Latour-Perez J. Diaphragm and Lung Ultrasound to Predict Weaning Outcome: Systematic Review and Meta-Analysis. Chest. 2017 Dec;152(6):1140-1150. doi: 10.1016/j.chest.2017.08.028. Epub 2017 Aug 31.

    PMID: 28864053BACKGROUND
  • Ferrari G, De Filippi G, Elia F, Panero F, Volpicelli G, Apra F. Diaphragm ultrasound as a new index of discontinuation from mechanical ventilation. Crit Ultrasound J. 2014 Jun 7;6(1):8. doi: 10.1186/2036-7902-6-8. eCollection 2014.

    PMID: 24949192BACKGROUND
  • Boussuges A, Gole Y, Blanc P. Diaphragmatic motion studied by m-mode ultrasonography: methods, reproducibility, and normal values. Chest. 2009 Feb;135(2):391-400. doi: 10.1378/chest.08-1541. Epub 2008 Nov 18.

    PMID: 19017880BACKGROUND
  • Zambon M, Greco M, Bocchino S, Cabrini L, Beccaria PF, Zangrillo A. Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound: a systematic review. Intensive Care Med. 2017 Jan;43(1):29-38. doi: 10.1007/s00134-016-4524-z. Epub 2016 Sep 12.

    PMID: 27620292BACKGROUND
  • Matamis D, Soilemezi E, Tsagourias M, Akoumianaki E, Dimassi S, Boroli F, Richard JC, Brochard L. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013 May;39(5):801-10. doi: 10.1007/s00134-013-2823-1. Epub 2013 Jan 24.

    PMID: 23344830BACKGROUND
  • Dres M, Goligher EC, Heunks LMA, Brochard LJ. Critical illness-associated diaphragm weakness. Intensive Care Med. 2017 Oct;43(10):1441-1452. doi: 10.1007/s00134-017-4928-4. Epub 2017 Sep 15.

    PMID: 28917004BACKGROUND
  • Goligher EC, Fan E, Herridge MS, Murray A, Vorona S, Brace D, Rittayamai N, Lanys A, Tomlinson G, Singh JM, Bolz SS, Rubenfeld GD, Kavanagh BP, Brochard LJ, Ferguson ND. Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort. Am J Respir Crit Care Med. 2015 Nov 1;192(9):1080-8. doi: 10.1164/rccm.201503-0620OC.

    PMID: 26167730BACKGROUND
  • Powers SK, Wiggs MP, Sollanek KJ, Smuder AJ. Ventilator-induced diaphragm dysfunction: cause and effect. Am J Physiol Regul Integr Comp Physiol. 2013 Sep;305(5):R464-77. doi: 10.1152/ajpregu.00231.2013. Epub 2013 Jul 10.

    PMID: 23842681BACKGROUND
  • Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008 Mar 27;358(13):1327-35. doi: 10.1056/NEJMoa070447.

    PMID: 18367735BACKGROUND
  • Supinski GS, Callahan LA. Diaphragm weakness in mechanically ventilated critically ill patients. Crit Care. 2013 Jun 20;17(3):R120. doi: 10.1186/cc12792.

    PMID: 23786764BACKGROUND
  • Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.

    PMID: 26903337BACKGROUND
  • Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009 Oct;37(10 Suppl):S354-67. doi: 10.1097/CCM.0b013e3181b6e439.

    PMID: 20046121BACKGROUND
  • Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018 Jul 7;392(10141):75-87. doi: 10.1016/S0140-6736(18)30696-2. Epub 2018 Jun 21.

    PMID: 29937192BACKGROUND
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.

    PMID: 26903338BACKGROUND

MeSH Terms

Conditions

Respiratory InsufficiencyShock, Septic

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Refaat Fathy Abdelaal, professor

    Assiut University

    STUDY DIRECTOR
  • Dina Ali Ahmed, doctor

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Abdallah Gamal Abd El Hafeez, Master

CONTACT

Dina Ali Ahmed, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Internal Medicine Specialist

Study Record Dates

First Submitted

September 4, 2026

First Posted

September 15, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

March 15, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

September 15, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations